Introduction {#Sec1}
============

Studies into metabolism have generally concentrated on individual metabolic pathways with a focus on specific metabolic functions (e.g. glycolysis). The development of global and high throughput metabolomic techniques has made it possible to investigate metabolism at the scale of the global metabolic network, which is the union of all pathways and can be formally defined as "a collection of objects and the relations among them. The objects correspond to chemical compounds, biochemical reactions, enzymes and genes" (Lacroix et al. [@CR19]).

The representation proposed by the BioCyc Cellular Overview is an increasingly popular style of visualising individual pathways in many organisms (Paley and Karp [@CR21]) (Fig. [1](#Fig1){ref-type="fig"}a, a′). Within the BioCyc architecture, nodes belonging to different pathways are duplicated, since the objective of that visualisation is to prioritise the pathway as the central feature (see (Bourqui et al. [@CR7]) for a discussion on node duplication). Such duplication of nodes is advantageous when considering individual pathways, but fails to capture linkage information of metabolites belonging to multiple pathways. Insight into the whole network is gained by removing duplication and connecting metabolites to all possible neighbours. However, this results in a much higher complexity as can be seen in Fig. [1](#Fig1){ref-type="fig"}, where the nodes representing identified metabolites were coloured green (Fig. [1](#Fig1){ref-type="fig"}b, b′). Zooming into local parts of the total representation reveals a dense mesh of edges, caused by the high degree of connectivity across the network (Jeong et al. [@CR14]) (Fig. [1](#Fig1){ref-type="fig"}c, c′). This complexity confounds the objective of creating interpretable metabolomics networks. A major aim therefore, is to reduce the complexity of the visual representations of metabolic networks, thus enabling extraction of relevant information. To do so, we have developed a method that constructs a sub-network containing the selected metabolites, regardless of their occurrence in disparate metabolic pathways. Fig. [2](#Fig2){ref-type="fig"} shows the result of this method (note that all of the identified metabolites are present in the drawing and most of them are connected).Fig. 1Each panel corresponds to one of two separate datasets: the *upper panel* is from *Trypanosma brucei* and the *lower* from HepG2 cells (human liver cells). **a,a′** Parts of cellular overview diagram from BioCyc, *grey boxes* represent pathways and green nodes identified metabolites. **b**, **b′** Metabolic network visualized using Cytoscape, *green nodes* are identified metabolites. **c**, **c′** Zoomed in view of the networkFig. 2**a***Trypanosoma brucei* metabolic network (derived from the BioCyc database) with identified metabolites highlighted in *green*. **b** Sub-network extracted by our method where all the identified metabolites are present (*green nodes*), reactions and metabolites, whose presence is inferred based on the BioCyc reconstruction, were added to create a pseudo-complete and descriptive sub-network (*smaller nodes*)

Truly comprehensive "metabolomic" data acquisition does not yet exist. A variety of measurement tools (e.g. LC--MS, GC--MS) and extraction methods (e.g. ethanol, acetonitrile, methanol, water and various gradients) exist (Fiehn [@CR11]), but the combination of all approaches in individual experiments is rarely possible. Networks built solely on identified metabolites from such sparse datasets have limits to their overall utility. Approaches where inference is combined with observation, can, therefore, be helpful in terms of data mining. Here we introduce a methodology that applies such an approach to two datasets acquired with the high-resolution LTQ-Orbitrap in an LC--MS setup. The first dataset is derived from the parasitic protozoan *Trypanosoma brucei*, which is the causative agent of human African trypanosomiasis (Barrett et al. [@CR6]). The second dataset is derived from human liver cells (HepG2). We were able to extract biologically relevant metabolic sub-networks for both datasets. The gap filling process allowed us to connect identified metabolites and detection of metabolites that had been discarded during the data pre-processing or simply were not detected due to the LTQ-Orbitrap configuration.

The algorithm presented in this article can be used on our web server called MetExplore (<http://metexplore.toulouse.inra.fr/metexplore/>).

Materials and methods {#Sec2}
=====================

Metabolomics data generation and processing {#Sec3}
-------------------------------------------

### Metabolite extraction from trypanosomes {#Sec4}

Metabolite extraction and quantification was performed as described in (Kamleh et al. [@CR15]).In brief, pooled cells were pelleted at 1,250 RCF (4°C, 10 min), re-suspended in 1 ml of serum free medium, and kept on ice whilst measuring cell density. The volume was adjusted to a final concentration of 10^9^ cells/ml, and the cells incubated at 28°C for 30 min to allow steady-state metabolism to re-establish. Total metabolites were extracted by adding 200 μl of concentrated cell suspension (at 10^9^ cells/ml) to 800 μl of 100% ethanol at 80°C for 2 min. For the measurements, a ZIC-HILIC HPLC (5 μm 150 × 4.6 mm; HiChrom, Reading UK) was coupled to an LTQ-Orbitrap (Thermo Scientific). Both positive and negative ionization centroid mode were registered in two separate runs, with a mass scanning range of 50--1200 *m/z* and a resolution of 30,000.

### Metabolite extraction from HepG2 cells {#Sec5}

HepG2 cells were grown in DMEM medium supplemented with FBS, [l]{.smallcaps}-glutamine, penicillin and streptomycin. Medium was removed and kept at −20°C (medium sample) and cells were scraped into acetonitrile/water (50:50, v:v) and frozen (cell sample). Medium and cell samples were concentrated under vacuum. Proteins were precipitated by adding ethanol and centrifugation. Supernatants were concentrated again by vacuum before LC--MS analysis. LC was performed on a C18 column (2 mm I.D.) using H~2~O/acetonitrile gradient elution.

Mass spectrometric data were generated on an LTQ-Orbitrap hybrid instrument coupled to a Surveyor LC system. Samples were diluted tenfold before injection (10 μl) onto a Hypercarb LC column (Thermo Fisher, Les Ulis, France). Compounds were separated using a water--0.5% acetic acid (solvent A) and acetonitrile (solvent B) gradient at a flow rate of 0.2 ml/min by varying solvent B. Mass spectrometric acquisition was carried out using positive electrospray ionisation and collecting data from *m/z* 100 to *m/z* 700 at a resolution power of 30,000. Exact mass measurements were achieved by external calibration.

### Data processing {#Sec6}

Data for the HepG2 cell was recorded in profile mode and converted to centroid mode with ReadW (<http://sashimi.sourceforge.net/software_glossolalia.html>). Signals were extracted with a "greedy" approach, resulting in all real signals but also a large number of noise signals. Signals from technical and biological replicates were grouped together into a replicate-set. For this project only reproducible signals were considered of interest, expressed as a RSD (Relative Standard Deviation) value of less than 35%. The LTQ-Orbitrap is expected to quantify metabolites from the same sample reproducibly within 20% (Shah et al. [@CR24]), which was extended to take minor biological variation into account. After this step the replicate sets are combined into one global set. Peaks removed by the RSD filter matching reproducible peaks of the other set were recovered. The remaining noise was removed with the CoDA-DW approach (Windig et al. [@CR27]). As a last measure extensive de-isotoping and other related peak removal based on correlation analysis of intensity patterns and peak shapes is performed (Scheltema et al.; bioanalysis December 2009---in press), ensuring that mostly signals of interest are included for further analysis.

Metabolic networks {#Sec7}
------------------

### Mass mapping {#Sec8}

High resolution mass spectrometry facilitates identification of metabolites by exact mass mapping to, for example, the KEGG database (Breitling et al. [@CR8]). This mapping is not completely satisfactory as isomeric compounds (e.g. fructose and glucose) cannot be discriminated, unless standard compounds are used as reference for retention time comparison, or use of orthogonal approaches such as fragmentation patterns generated by tandem mass spectrometry. In addition, the electrospray ionisation process is known to be subject to matrix effects and ion suppression (Annesley [@CR1]) and to some selectivity, thus hindering collection of certain compounds (Cech and Enke [@CR9]). In our approach we chose to take all the possible isomers for a given exact mass into account as a first approximation, with a user definable mass range of 2 ppm. This approach is similar to that proposed in Masstrix (Suhre and Schmitt-Kopplin [@CR26]), which is a web server allowing mass mapping to KEGG maps. To circumvent the limitations of mass mapping, however, the application can also be supplied with a list of BioCyc identifiers instead of the masses. In this case it is assumed that the user has made a correct interpretation of the mass spectrum.

### Network reconstruction {#Sec9}

Both networks were derived from metabolic reconstructions made by the Pathologic tool used to build BioCyc-like databases (Karp et al. [@CR17]). This tool determines a putative list of biochemical reactions by comparing a list of around 7,500 genes (from curated metabolic data of more than 1,600 organisms) with assigned enzymatic functions to the genome of the organism in question. The appropriate data for *Trypanosoma brucei* and Human dataset was derived from TrypanoCyc (Chukualim et al. [@CR10]) and HumanCyc (Romero et al. [@CR23]) respectively.

### Graph model and filtering {#Sec10}

The metabolic network was modelled as a bipartite graph, which is composed of two types of nodes: corresponding here respectively to the reactions and to the metabolites (see Fig. [3](#Fig3){ref-type="fig"}). There is an edge between a metabolite and a reaction node if the metabolite is a substrate of the reaction, and there is an edge between a reaction and a metabolite node if the reaction produces the metabolite. Each edge has an arrow indicating its relation to the reaction and reaction nodes are filled with a colour according to their reversibility. Unlike simple metabolic graphs, which are characterised by a single type of node (compounds or reactions), the models represented here depict the complete linkage pattern between the set of substrates and the set of products of a reaction. In those cases where the direction of the reaction is not strictly defined in the metabolic databases, the direction is determined as follows: if a reaction occurs in the same direction, whatever the metabolic pathway in MetaCyc, then the reaction is considered irreversible and a direction is assigned. Conversely, if a reaction occurs in two directions according to MetaCyc pathway attributes, then the reaction is assigned as reversible. As any reaction can be reversible under the correct thermodynamic conditions we confine ourselves, in this first approximation, to database assignments on reversibility, although manual curation is possible.Fig. 3The *upper panel* shows a textual description of a reaction. The *lower panel* shows the bipartite graph modelling of this reaction. *Blue nodes* are metabolite and the *pink node* is the reaction. *Arrows* indicate the direction of a reaction, but in that case the reaction is reversible which is indicated by *red border* of the reaction node

To obtain a faithful and interpretable metabolic network it is necessary to apply filters to the primary network built on all metabolites and reactions listed in a database. For example nodes that short circuit the network (e.g. water and the common "currency metabolites" including ATP, ADP, NAD(H), NADP(H) and other cofactors) as well as higher molecular weight cellular components (nucleic acids, proteins, glycoconjugates etc.) must be pruned (Arita [@CR5]). For this purpose, we used a published list of 59 cofactor transformations (Handorf et al. [@CR12]), of which 32 were present in the *T. brucei* network and 44 in the *Homo sapiens* network. The reduced *T. brucei* metabolic network contains 925 reactions, 922 compounds, and 2113 edges and the reduced *Homo sapiens* metabolic network (considered here as the HepG2 network) contains 1,416 reactions, 1,402 compounds, and 3,379 edges. Finally, the filtered metabolic network was exported into edge-lists and attribute files, which can be read by the biochemical network visualization software Cytoscape (Shannon et al. [@CR25]).

Metabolic sub-network extraction and gap filling {#Sec11}
------------------------------------------------

### Sub-network extraction {#Sec12}

The simplest method of extracting sub-networks involves retaining only those metabolites identified in a given experiment. In this case a reaction is kept when its substrates and products are present in the set of all identified metabolites (for example see Fig. [4](#Fig4){ref-type="fig"}a, c). However, such a sub-network can be very sparse and difficult to interpret. For instance, when applying this method to the *T. brucei* dataset, 17 of the 91 identified metabolites are not connected to any other metabolites (isolated nodes on Fig. [4](#Fig4){ref-type="fig"}c) and thus cannot be integrated directly into a metabolic reaction or a metabolic process. To overcome this problem we propose to extend the sub-network extraction using a gap filling algorithm.Fig. 4**a** Sub-network extracted with only identified compounds for HepG2 cells. **b** Sub-network with gaps filled for HepG2 cells. **c** Sub-network extracted with only identified compounds for the trypanosome. **d** Sub-network with gap filled for the trypanosome

### Gap filling {#Sec13}

Several methods already exist for finding paths between two metabolites (Arita [@CR4]; Rahman et al. [@CR22]). However, these methods do not check the availability of the co-substrates, while in fact a reaction should be taken into account if all its co-substrates are present. For instance in Fig. [5](#Fig5){ref-type="fig"}b metabolite H belongs to a path connecting E and I, but the reaction requires F if it is to be fired. This notion of co-substrate necessity is used by the method which looks for the *scope* of a set of compounds, where the scope is the set of compounds that can be produced from a set of seed compounds (Handorf et al. [@CR13]). The method to compute such a scope is iterative. At each iteration, the reactions are considered and found feasible (fired) if all of its substrates are in the seed set. When this is the case, all of the products of the reactions are added to the seed set and the method re-iterates. The process stops when the last iteration fails to fire any reaction. Figure [5](#Fig5){ref-type="fig"}c shows the scope on a set of identified compounds, note that H is not in the scope as F is not an available compound.Fig. 5Different options to connect identified metabolites. **a** The input network where *green nodes* are identified metabolites. **b***Purple nodes* belong to simple paths between identified metabolites. **c***Purple nodes* belong to the scope of all the identified metabolites. **d***Purple nodes* belong to a path defined by our gap filling algorithm

Our approach improves this since we do not take metabolites into account that are not on the path between two identified metabolites. For instance metabolites D and G in Fig. [5](#Fig5){ref-type="fig"} will not be selected. The adapted scope algorithm works as follows. For each identified metabolite we look at all of the reactions that use this metabolite as a substrate. If all of the other substrates of this reaction are present in the dataset, we consider all of the products of the reaction as potential candidates. For each of these candidates, we search the list of all reactions for which the candidate is a substrate. If for at least one of these reactions all required substrates and products are present in the dataset, we consider that the metabolite in question is a relevant candidate. Finally, we add both the candidate metabolite and the associated reactions which helped us to localise it in the sub-network of the previous iteration. With this method only single metabolite gaps are captured, but by rerunning the process multiple times larger gaps can be filled. We have tried this, however the significance of these results (discussed in the next section) and the biological relevance of networks built with a single gap barely improved on subsequent iterations.

Results and discussion {#Sec14}
======================

Statistical significance of sub-networks {#Sec15}
----------------------------------------

In order to asses the quality of sub-networks we compute their statistical significance. The *P*-values obtained measure the probability that a random set of metabolites results in a more connected sub-network than one computed using the measured dataset. This is similar to the approach presented by (Antonov et al. [@CR2]). However, our method can result in multiple separately connected components, making it necessary to analyze the sub network individually. On the two datasets presented here, a single iteration of the gap filling algorithm resulted in a significant p-value of below 0.01 (verbatim use of the algorithm presented by Antonov et al. resulted in similar significance). When iterating the process *P*-values below 0.01 were also found.

Obtaining improved connectivity {#Sec16}
-------------------------------

Figure [4](#Fig4){ref-type="fig"}b and d show the result of our algorithm on the two different datasets studied here. For the *T. brucei* dataset (Fig. [4](#Fig4){ref-type="fig"}c, d) the number of unconnected compounds reduces from 17 to 9. The number of connected components (i.e. a sub-network in which any two nodes are connected by paths) is 17 (as opposed to 27 before application of the algorithm). For the HepG2 dataset the number of unconnected compounds reduces from 22 to 17. The number of connected components is 20 (as opposed to 27 before application of the algorithm). A comparison was also made for multiple iterations of the gap-filling procedure. However, the gain of connectivity was low, while the sub-network grew denser at each iteration (data not shown).

Biological relevance of sub-networks {#Sec17}
------------------------------------

Trypanosomes contain an unusual "signature" metabolite, trypanothione, that comprises two molecules of glutathione linked through a spermidine. Its presence, along with metabolites involved in its biosynthesis, offers an interesting proof of concept for the pathway extraction method. Fig. [6](#Fig6){ref-type="fig"} shows that the trypanothione biosynthetic pathway sub-network was indeed correctly extracted.Fig. 6*Green nodes* are metabolites identified in the dataset. *Purple nodes* are the ones inferred by our gap filling method. *Square nodes* are reactions nodes, when the border is *red* it means that the reaction can occur in both directions. This pathway is part of amino acids degradation. The sub-network reported here was produced from the current version of Trypanocyc. It is notable that this version has not benefited from expert pruning so the reactions catalysed by spermine synthase and spermidine dehydrogenase have not been reported in *T. brucei*. Furthermore the reaction catalysed by trypanothione reductase, usually converts the oxidised form of trypanothione to its reduced form, which is then involved in multiple cellular reductions prior to its being enzymatically reconverted to the reduced form

The HepG2 cells were derived from a human hepatocellular carcinoma and are a commonly used hepatocyte model cell line. The subnetworks we extracted dealt with major hepatic metabolic pathways, such as deamination of amino-acids and catabolism of nucleic acids. We identified some metabolites from the urea cycle (including citrulline and arginine), which occurs specifically in the liver. Moreover, glutamine and glutamate were also present in the liver. Finally, metabolites associated with purine (Fig. [7](#Fig7){ref-type="fig"}a) and pyrimidine (Fig. [7](#Fig7){ref-type="fig"}b) pathways were detected (adenosine, hypoxanthine, cytosine and uracil). These pathways are linked by ribose 1-phosphate (whose presence is inferred from the reconstruction method) and also converge in production of ammonia whose presence is also inferred (ammonia being too small to be found in the mass spectrometry experiments used here) and links the urea cycle and glutamate metabolism in liver. This demonstrates how sparse datasets can be linked across modules using the automated procedure outlined here.Fig. 7Sub-networks for HepG2 cell experiment. **a** Purine pathway. **b** Pyrimidine pathway

The gap filling process enhances metabolomics raw data processing {#Sec18}
-----------------------------------------------------------------

To obtain a comprehensive view using mass spectrometry requires a combination of different sample preparation techniques, solvents, chromatography types and detection systems. Comprehensive metabolomics is thus seldom, if ever, possible for most experimental setups. An example of such a sparse collection is the HepG2 dataset, which was acquired only in positive ionisation mode with a mass range of 100--700 amu. Thus all metabolites exclusively detectable in negative ionisation mode or outside the mass range are not included in the dataset. Additionally, a number of metabolites were removed from the dataset by the pre-processing method. However, by exploiting the gap filling process it was possible to extract parts of the network which contained precisely those metabolites (see Table [1](#Tab1){ref-type="table"} for a complete overview). For example, several acidic compounds such as 2-keto-6-aminocaproate, 4-(3-pyridyl)-3-butenoate, *O*-succinyl-homoserine or phosphorylated compounds were not observed, likely due to unfavourable ionisation conditions (although these conditions notably did allow the detection of phenylpyruvate) while their presence could be inferred based on the presence of observed masses and using the gap-filling algorithm within the context of the known metabolic network.Table 1List of predicted metabolites using the gap filling methodNameFormulaMass^a^ObservationAmmoniaH~3~N~1~17.02600Below mass acquisition rangeAcetaldehydeC~2~H~4~O~1~44.02567Below mass acquisition rangeGlycineC~2~H~5~N~1~O~2~75.03148Below mass acquisition range[l]{.smallcaps}-AlanineC~3~H~7~N~1~O~2~89.04713Bellow mass acquisition rangeDihydrouracilC~4~H~6~N~2~O~2~114.04238Observed5-AminopentanamideC~5~H~12~N~2~O~1~116.09441Observed[l]{.smallcaps}-CysteineC~3~H~7~N~1~O~2~S~1~121.01920Observed[l]{.smallcaps}-Glutamate gamma-semialdehydeC~5~H~9~N~1~O~3~131.05769Observed[l]{.smallcaps}-HomocysteineC~4~H~9~N~1~O~2~S~1~135.03485Not observed in positive mode2-Keto-6-aminocaproateC~6~H~11~N~1~O~3~145.07334Not observed in positive mode4-(3-Pyridyl)-3-butenoateC~9~H~9~N~1~O~2~163.06278Not observed in positive modePhenylpyruvateC~9~H~8~O~3~164.04680Observed*O*-Phospho-[l]{.smallcaps}-homoserineC~4~H~10~N~1~O~6~P~1~199.02402Not observed in positive modeDeoxyribose 1-phosphateC~5~H~11~O~7~P~1~214.02369Not observed in positive mode*O*-Succinyl-[l]{.smallcaps}-homoserineC~8~H~13~N~1~O~6~219.07374Not observed in positive modeRibose 1-phosphateC~5~H~11~O~8~P~1~230.01861Not observed in positive modeDeoxyadenosineC~10~H~13~N~5~O~3~251.10129ObservedInosine 5′-phosphateC~10~H~13~N~4~O~8~P~1~348.04655Not observed in positive modeThe last column presents the result of the mass spectrometric analysis based on the detection of metabolite MH^+^ ions^a^Calculated mass for the considered metabolite (the searched m/z ratio were 1.00723 mass unit above due to protonation)

Reducing network analysis complexity through enhanced visualization {#Sec19}
-------------------------------------------------------------------

The two examples we described above show that our method allows improved biological interpretation of datasets as well as providing a convenient and accessible means for visualisation. By presenting data within the context of the global metabolic network, rather than the fragmented pathway representation, characteristic of other metabolic pathway visualisation tools (e.g. BioCyc (Karp et al. [@CR18]) and KEGG (Aoki and Kanehisa [@CR3]; Kanehisa et al. [@CR16]; Okuda et al. [@CR20]), the new method permits enhanced contextualisation of identified metabolites. This can be particularly useful when considering subsets of the organism's total metabolic potential as is usually seen in cell-type specific expression patterns. With the integration of our method into Cytoscape (which already offers many functions to represent biological networks) and the ability to import datasets, we offer a very easily navigable tool to visualise and mine metabolomics datasets.

Recently, Antonov et al. ([@CR2]) proposed a web tool which also offers the capability of highlighting metabolites identified in metabolomics experiments within the context of known metabolic pathways. However, this graph model does not take the plurality of the substrates in a reaction into account. So far our approach is restricted to a single reaction gap, while Antonov et al. permit multiple absent steps by using a shortest path principle. Clearly additional routes to gap filling are desirable for these types of visualization and this will be a focus of our continuing efforts in this area.

Concluding remarks {#Sec20}
==================

Metabolic networks provide what is, arguably, the best context for interpretation of metabolomics data. Classical approaches consist of highlighting metabolites within the represented global network. However, this generally results in a representation overload, in which individual metabolic processes cannot be readily traced. Our aim was to lower the complexity of the network structure that connects compounds in a given experiment. We propose an approach based on sub-network extraction and a gap filling algorithm, which takes reaction direction and substrate availability into account. As we have shown, such an approach helps in creating a connected sub-network, while also resulting in a better interpretation of data acquired in metabolomics experiments. Based on the investigated data, we were able to identify biologically relevant sub-networks. Moreover, manual data mining in the raw spectra confirmed that those metabolites identified by the gap filling algorithm were relevant to the context of those experimentally measured. Some metabolites remain un-connected using our approach and we plan future developments to allow use of multiple steps in filling gaps between metabolites. A part of this effort will be directed towards taking localisation of metabolites within cells into account. It is important to recognise that even Orbitrap data, with mass accuracies better than 1 ppm and resolution up to 600,000 requires orthogonal approaches to provide true identification of metabolites. The algorithm itself works well and users must ensure the robustness of their metabolite identification in exploiting the tool.
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